Evidence map›Paper›PMID 24461721›Full record

ArticleJournal of Crohn's & colitis2014

SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease.

Sharyle A Fowler, Ashwin N Ananthakrishnan, Agnes Gardet, Christine R Stevens, Joshua R Korzenik, Bruce E Sands, Mark J Daly, Ramnik J Xavier, Vijay Yajnik

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Crohn's & colitis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. International journal of molecular sciences · 2020
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Sharyle A FowlerGastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ashwin N AnanthakrishnanGastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Agnes GardetGastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA, USA.
Christine R StevensThe Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Joshua R KorzenikGastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Bruce E SandsDivision of Gastroenterology, Mount Sinai School of Medicine, New York, NY, USA.
Mark J DalyCenter for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA, USA.
Ramnik J XavierGastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA, USA.
Vijay YajnikGastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: VYAJNIK@PARTNERS.ORG.
Harvard University · USBroad Institute · USIcahn School of Medicine at Mount Sinai · USMassachusetts General Hospital · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WAYNE I LENCER · 1986 to 2026
$32.4M
NIDDK NIH HHS P30 DK034854NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30DK043351
6 · The paper itself

Abstract

BACKGROUND AND

aimsMore than 80% of Crohn's disease (CD) patients will require surgery. Surgery is not curative and rates of re-operation are high. Identification of genetic variants associated with repeat surgery would allow risk stratification of patients who may benefit from early aggressive therapy and/or post-operative prophylactic treatment.

methodsCD patients who had at least one CD-related bowel resection were identified from the Prospective Registry in IBD Study at Massachusetts General Hospital (PRISM). The primary outcome was surgical recurrence. Covariates and potential interactions were assessed using the Cox proportional hazard model. Kaplan-Meier curves for time to surgical recurrence were developed for each genetic variant and analyzed with the log-rank test.

results194 patients were identified who had at least 1 resection. Of these, 69 had two or more resections. Clinical predictors for repeat surgery were stricturing (HR 4.18, p=0.022) and penetrating behavior (HR 3.97, p=0.024). Smoking cessation was protective for repeat surgery (HR 0.45, p=0.018). SMAD3 homozygosity for the risk allele was also independently associated with increased risk of repeat surgery (HR 4.04, p=0.001). NOD2 was not associated with increased risk of surgical recurrence.

conclusionStricturing and penetrating behavior were associated with increased risk of surgical recurrence, while smoking cessation was associated with a decreased risk. A novel association between SMAD3 and increased risk of repeat operation and shorter time to repeat surgery was observed. This finding is of particular interest as SMAD3 may represent a new therapeutic target specifically for prevention of post-surgical disease recurrence.

Indexed as

AdolescentAdultAgedChildChild, PreschoolCrohn DiseaseFemaleGenotyping TechniquesHumansKaplan-Meier EstimateMaleMiddle AgedPolymorphism, Single NucleotideRegistriesReoperationRisk FactorsSmad3 ProteinSMAD3 protein, humanCrohn's diseaseGenotype/clinical phenotypeNOD2SMAD3Surgery for IBD

Identifiers

PMID24461721
PMCPMC4237062
OpenAlexW2073526681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.